Mr Przemyslaw Kozanecki
(Poland)
Follow
Contributor content
![Preclinical evaluation of [18F]SYN2, a novel radiotracer for myocardial perfusion imaging in PET](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/ehjcimaging/Issue/25/Supplement_1/1/m_ehjcimaging_25_suppl_1cover.jpeg?Expires=2147483647&Signature=WBl6jNZ71Alu05QR7Gv~idHTfqibHUSvAtarGnXxbaNKn52B7CKLDnRdjxn634hn3IH3d5DdJ4ieQqvwfkzulnR52ud~XKZYuoD1SnZcQ3yyMDJ11yvkhtb2W9UbKhw0bX2aYNsX92kaubMRFgsXG15pxpDWFSzr8FWk0QczK0~tGaWh1XkU6lI4KVB8et62D1xIsQ0zLDBfbhN-hpQWP8Iz4GMa~v1FZrU0fztTi66Py8QeLVLY0DkzpGHN8bSS9ldoLoMuPYZeO372qiRl78cT9OGb64L9KcjOdubAqQLojndtbSwbX2aQx-6uLAmAc06ezuzJp8MxBo7eBghQWg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Journal
Preclinical evaluation of [18F]SYN2, a novel radiotracer for myocardial perfusion imaging in PET
27 June 2024
Journal
Safety, tolerability and diagnostic ability of a novel 18F-labelled tracer, [18F]SYN2, for PET myocardial perfusion imaging (SAFER) in patients with suspected coronary artery disease - phase II trial
27 June 2024
